Aditxt Inc (NASDAQ: ADTX) has announced data from Phase 3 PRESECO trial evaluating oral Avigan/Reeqonus (favipiravir) as a potential at-home therapy for mild-to-moderate COVID-19, run by Appili Therapeutics Inc.
The trial did not achieve statistical significance on the primary endpoint of time …
Original Post: benzinga.com
Truist Sees 350% Upside on This Cancer-Focused Biopharma Stock – Read Why
Truist has initiated coverage on Verastem Oncology Inc (NASDAQ: VSTM) with a Buy rating and $6.00 price target, equivalent to approximately 350% upside.
Analyst Srikripa Devarakonda notes that trading at about 2-times cash, the stock is “undervalued” given its programs in two cancers.
Devarakonda adds that the Verastem base case is supported by a $470 million unadjusted U.S. opportunity in the ovarian cancer program, “early but strong” clinical data, and positive expert feedback.
“Peek Performance”: Apple’s Next Hardware Event Happens on March 8
Apple will stream its next hardware event to the masses on March 8 at 10 am Pacific (1 pm Eastern), the company announced today. Invitations have already been sent to the press—though the event will be yet another prerecorded, streaming-only presentation with no media in attendance. Apple marketing SVP Greg Joswiak tweeted the now-customary Apple-logo-centric teaser video that doesn’t actually tease anything.
We never know exactly what will be announced at any given Apple event, but Bloomberg’s Mark Gurman reports that the lineup will include a refresh of the budget-friendly iPhone SE and the first iPad Air update in a little over a year.
Rumors have also circulated about updated designs and new Apple Silicon chips for the MacBook Air and the 13-inch MacBook Pro, and the high-end Intel Mac Mini, the 27-inch iMac, and the Mac Pro are all still running Intel chips. The characteristically cryptic “peek performance” tagline does at least hint at new chips for one or more Macs, whether that’s a truly next-gen Apple M2 for thin-and-light laptops or an M1 Pro/Max-focused refresh for the more powerful desktops.
Original Article: arstechnica.com
Charles River’s Q4 Earnings Beats Street Expectation, Reaffirms FY22 Outlook
Acquisitions contributed 5.9% to consolidated fourth-quarter revenue growth. Organic revenue growth was 10.5%, driven by contributions from all three business segments.
Adjusted EPS reached $2.49 higher than $2.39 posted a year ago and …
News7 months ago
Primal Season 2 Release Date, Plot, Cast, and Latest Updates 2021
Personal Finance7 months ago
Black Friday Cricut Deals (2021): Early Cricut Maker 3, Explore 3…
Arts4 months ago
Canada Pulls Out More Personnel From Embassy in Ukraine
Medical7 months ago
Social Media Analysis Shows Support for Public Health Measures
Technology7 months ago
MacOS 12 Monterey: the Ars Technica Review
News7 months ago
Knowing More About Mediclaim Policies in Ahmedabad
Cars and Trucks7 months ago
2022 Kia Niro
Arts7 months ago
2,000 Migrants Continue Trek Through Southern Mexico